![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600-150x150.jpg "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37] 24")
GLP-1 Receptor Agonist Clinical Evidence: Thyroid Eye Disease
GLP-1 receptor agonist clinical evidence and outcomes suggest potential benefits for thyroid eye disease through metabolic improvements. These drugs may reduce systemic inflammation and improve glycemic control. Clinicians should monitor patients with…
GLP-1 Drugs & Generic Weight-Loss Medicine: Market Shifts
Generic weight-loss medications are entering international markets, creating significant shifts in the GLP-1 drug landscape. These generics impact pricing and availability, affecting patient access and clinical decisions. Understanding these market…
Understanding GLP-1 Receptor Agonist Side Effects on Relationships
GLP-1 receptor agonists clinical evidence and uses reveal important side effects on relationships. These medications can affect mood, libido, and interpersonal dynamics. Clinicians should monitor these psychosocial changes carefully during treatment.
GLP-1 Receptor Agonist Resistance: Stanford’s Key Findings
GLP-1 receptor pharmacogenomics reveals that about 10% of patients carry genetic variants reducing response to GLP-1 receptor agonists. This resistance affects glycemic control and treatment outcomes. Understanding these genetic factors is crucial for…
Cognitive performance and subjective effects the morning after last use of smoked cannabis by adults who use cannabis frequently: An observational study.
This observational study investigates cognitive performance after cannabis use in frequent users. Results show no significant next-day impairment despite detectable THC levels. These findings provide insight into cognitive effects after cannabis use.
Medical Cannabis and Palliative Care: What This End-of-Life Study Actually Shows
This study examines medical cannabis and palliative care utilization among terminally diagnosed patients. It highlights patterns of cannabis use alongside or instead of nonhospice palliative care. The findings offer cautious insights but do not prove…
Acute Toxicity of ADB-CHMINACA – Case Series with Pronounced CNS Symptoms
This report presents a series of 16 patients with acute toxicity of ADB-CHMINACA confirmed by analytical testing. Patients exhibited pronounced central nervous system symptoms including panic attacks and seizures. The study highlights the dangers of…
Medicinal Cannabis Prescription Before Psychiatric Admission: Audit Results
This study investigates medicinal cannabis psychiatric inpatient use through a retrospective observational audit. It highlights prescription patterns and safety concerns in psychiatric populations. The findings provide important baseline data for…
Substance Use in Supportive Oncology and Its Impact on Clinical Outcomes and Care
Substance use in supportive oncology significantly influences clinical outcomes and treatment adherence. This review highlights the impact of alcohol, tobacco, cannabis, and opioids on cancer care. Understanding substance use patterns is essential for…
Older Adults Using Prescribed Cannabis Report Well-Being Improvements, But Causal Claims Remain Unsupported
Older aged individuals experience considerable improvement in health and well-being when prescribed cannabis-based medicinal products—though this is an observational registry without a control group, so causality cannot be established.